AZE/FLU Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)

Trial Profile

AZE/FLU Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Azelastine/fluticasone-propionate (Primary)
  • Indications Allergic rhinitis; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Dec 2015).
    • 09 Nov 2017 Results (n=28) published in the Allergy
    • 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top